Pharmaids Pharmaceuticals Share Price
30.27+0.59 (+1.99%)
-46.75% past 1 Year
Corporate filings & documents
Announcements
Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015 we hereby inform that the Company has filed two complaints on September 15 2026 against M/s Anugraha Chemicals ("the Firm") and its partners on account of dishonour of two cheques issued by the firm towards discharge of outstanding dues payable to the Company.
4 days agoPursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015 we hereby inform that the Company has filed two complaints on September 15 2026 against M/s Anugraha Chemicals ("the Firm") and its partners on account of dishonour of two cheques issued by the firm towards discharge of outstanding dues payable to the Company.
4 days agoVoting Results along with the Scrutinizers Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM.
5 days agoVoting Results along with the Scrutinizers Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM.
5 days agoOutcome of the 37th Annual General Meeting of the Company held on September 11 2026 i.e. today at 12 noon through VC/OAVM.
1 week agoOutcome of the 37th Annual General Meeting of the Company held on September 11 2026 i.e. today at 12 noon through VC/OAVM.
1 week agoEnclosed copies of Newspaper Advertisement published on August 19 2026 intimating the Notice of 37th Annual General Meeting of the Company
1 month agoEnclosed copies of Newspaper Advertisement published on August 19 2026 intimating the Notice of 37th Annual General Meeting of the Company
1 month agoAnnual Report
1 month agoAnnual Report
1 month agoNotice of 37th AGM and Annual Report
1 month agoNotice of 37th AGM and Annual Report
1 month agoNewspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30 2026
1 month agoNewspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30 2026
1 month agoSubmission of unaudited financial results
1 month agoSubmission of unaudited financial results
1 month agoOutcome of the Board meeting held today i.e. August 12 2026
1 month agoOutcome of the Board meeting held today i.e. August 12 2026
1 month agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026.
1 month agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026.
1 month agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months agoAppointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
2 months agoAppointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
2 months agoIntimation w.r.t Closure of Trading Window
2 months agoIntimation w.r.t Closure of Trading Window
2 months agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you of the change in Senior Management Personnel of the Company.
2 months agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you of the change in Senior Management Personnel of the Company.
2 months agoAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015 - Providing corporate guarantee to subsidiary Adita Bio Sys Private Limited
3 months agoAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015 - Providing corporate guarantee to subsidiary Adita Bio Sys Private Limited
3 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026
3 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026
3 months agoSubmission of Audited Financial Results along with Auditors Report.
3 months agoThe Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31 2026 at their meeting held on May 29 2026.
3 months agoThe Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31 2026 at their meeting held on May 29 2026.
3 months agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2026.
4 months agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2026.
4 months agoPursuant to the Regulation 24A of SEBI (LODR) Regulations 2015 enclosed is the Annual Secretarial Compliance Report for the year ended March 31 2026.
4 months agoNewspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
4 months agoNewspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
4 months agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.
5 months agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.
5 months agoSale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited a step-down subsidiary resulting in cessation of its subsidiary status w.e.f March 27 2026.
5 months agoSale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited a step-down subsidiary resulting in cessation of its subsidiary status w.e.f March 27 2026.
5 months agoIntimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.
5 months agoIntimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.
5 months agoIntimation under Regulation 30 of LODR.
6 months agoCorrigendum to the newspaper publication dated February 14 2026 regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
7 months agoCorrigendum to the newspaper publication dated February 14 2026 regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
7 months agoNewspaper Publication of unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found